Revitalize your health journey with the medical weight loss services at M. Zafar, MD, SC, serving Illinois statewide by Telehealth. The practice offers innovative weight loss strategies, including the use of Tirzepatide and Semaglutide. Schedule a Telehealth appointment today by conveniently booking online.
In the clinical trial, patients taking Tirzepatide lost on average up to 22.5% of their body weight depending on dose level. About one in three patients lost 25% or more of their body weight. All-inclusive pricing starts at just $275/month.
In the clinical trial, patients taking Semaglutide achieved an average 15% reduction in body weight after titrating up to the maximum target dose. One in three lost 20% or more of their body weight. All-inclusive pricing starts at just $198/month.
Medical weight loss is a personalized, medically-supervised approach to weight management. At M. Zafar, MD, SC, Dr. Zafar uses innovative treatments like Semaglutide and Tirzepatide to aid patients in achieving their weight loss goals.
These medications, along with lifestyle modifications, form the core of a comprehensive weight loss strategy.
Semaglutide and Tirzepatide are injectable medications that help control blood sugar levels and slow digestion, resulting in a reduced appetite and enhanced weight loss.
Dr. Zafar may recommend one of these medications as part of a comprehensive medical weight loss plan, considering the patient's health status and weight loss goals.
During a medical weight loss consultation at M. Zafar, MD, SC, Dr. Zafar conducts a thorough health assessment and discusses the patient's weight loss goals.
Based on this information, he may recommend treatments like Semaglutide or Tirzepatide.
These treatment plans are designed to be safe, effective, and suited to the individual's needs. Additionally, these are the lowest prices locally, and services can be offered statewide in Illinois via telehealth.
Yes, medical weight loss can significantly improve many health conditions associated with obesity, such as diabetes, hypertension, and heart disease. By achieving a healthier weight with the help of treatments like Semaglutide and Tirzepatide, patients can enhance their overall health and well-being.
Transform your health journey with Medical Weight Loss at M. Zafar, MD, SC, serving Illinois statewide by Telehealth. Schedule your appointment with Dr. Zafar today by conveniently booking online.
Wegovy™ and Ozempic™ are trademarks of Novo Nordisk. Mounjaro™ is a trademark of Eli Lilly and Company.